Antimetastatic activity of seongsanamide B in Î³-irradiated human lung cancer.

Ryoo, Ga-Hee; Kim, Geum Jin; Han, Ah-Reum; Jin, Chang Hyun; Lee, Hunmin; Nam, Joo-Won; Choi, Hyukjae; Jung, Chan-Hun

Ryoo, Ga-Hee; Kim, Geum Jin; Han, Ah-Reum; Jin, Chang Hyun; Lee, Hunmin; Nam, Joo-Won; Choi, Hyukjae; Jung, Chan-Hun.

Afiliação

Ryoo GH; Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup-si, Jeollabuk-do, 56212, South Korea.
Kim GJ; College of Pharmacy, Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, 38541, South Korea.
Han AR; Research Institute of Cell Culture, Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, 38541, South Korea.
Jin CH; Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup-si, Jeollabuk-do, 56212, South Korea.
Lee H; Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup-si, Jeollabuk-do, 56212, South Korea.
Nam JW; College of Pharmacy, Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, 38541, South Korea.
Choi H; College of Pharmacy, Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, 38541, South Korea.
Jung CH; College of Pharmacy, Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, 38541, South Korea.

Heliyon ; 9(9): e20179, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37809399

Palavras-chave

Lung cancer; Metastasis; Radiation therapy enhancer; Seongsanamide B

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Coréia do Sul País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google